½áºË·ÖÖ¦¸Ë¾ú£¨M. tuberculosis, Mtb£©¸ÐȾÒýÆðµÄ½áºË²¡£¨Tuberculosis, TB£©ÊÇÖØÒªµÄÖÂËÀÐÔÂýÐÔ´«È¾²¡£¬ÑÏÖØÍþвȫÇòÈËÀཡ¿µ¡£¾ÝÊÀ½çÎÀÉú×éÖ¯£¨WHO£©±¨µÀ£¬2019ÄêÈ«ÇòÔ¼ÓÐ1000Íòз¢TB»¼Õߣ¬Ô¼ÓÐ141ÍòÈËËÀÓÚTB¡£MtbÊÇÒ»ÖÖ¼æÐÔ°ûÄÚ¼ÄÉú¾ú£¬ÆäÄܹ»ÔËÓöàÖÖ²ßÂÔ¸ÉÔ¤ËÞÖ÷ϸ°ûµÄÕý³£¹¦ÄÜ´Ó¶øÌÓÒÝËÞÖ÷ÃâÒß·´Ó¦£¬½ø¶øÊµÏÖÆäÔÚËÞÖ÷ϸ°ûµÄ³¤ÆÚ´æ»î¡£Öйú¿ÆÑ§ÔºvwinµÂÓ®Ñо¿ËùÁõ´ä»ªÑо¿×鳤ÆÚÖÂÁ¦ÓÚÑо¿MtbµÈÖØÒª²¡Ô­¾ú¸ÐȾÓëËÞÖ÷ÃâÒßµ÷¿ØÐ»úÖÆ£¬ÓÈÆä¾Û½¹Mtbͨ¹ý½Ù³ÖËÞÖ÷·ºËØÏµÍ³ÊµÏÖÃâÒßÌÓÒݵÄлúÖÆÒÔ¼°ËÞÖ÷·ºËØÏµÍ³´Ù½ø¿¹¸ÐȾ¹ÌÓÐÃâÒß¹¦ÄܵķÖ×Ó»úÖÆ£¬½üÄêÀ´ÏȺóÔÚNature Immunology¡¢Nature Communication¡¢proc Natl Acad Sci¡¢Cellular & Molecular ImmunologyµÈÔÓÖ¾·¢±íϵÁÐÑо¿¹¤×÷£¬½ÒʾÁ˲¡Ô­¾úÓëËÞÖ÷¼äÏ໥²©ÞĵĶ¯Ì¬¹ý³Ì¼°·Ö×Ó»úÀí£¬Îª¿¹½áºËÖÎÁƼ°Ò©ÎïÑз¢ÌṩÁËÐÂ˼·ºÍÌØÒì°Ðµã¡£

Mtb±àÂëһϵÁÐÕæºËÑùÁ×Ëáø/¼¤Ã¸¼Ò×åµ°°×£¬ÆäÖÐÕæºËÑùÀÒ°±ËáÁ×ËáøptpAºÍÕæºËÑùË¿°±Ëá/ËÕ°±Ëáµ°°×¼¤Ã¸pknG¾ùΪ·ÖÃÚÐÔЧӦµ°°×£¬ÇÒÓëMtbµÄ°ûÄÚ´æ»î¹ý³ÌÃÜÇÐÏà¹Ø£¬Òò´ËMtb ptpAºÍMtb pknGÒ»Ö±ÊÇÑз¢¿¹½áºËÐÂÒ©µÄDZÔÚÖØÒª°Ðµã£¬µ«Ä¿Ç°¹ØÓÚÆäµ÷¿ØËÞÖ÷ÃâÒß¹¦ÄܵľßÌå»úÖÆ£¬°üÀ¨Ïà¹ØµÄϸ°ûÉúÎïѧ¹ý³Ì¡¢¹Ø¼üÐźÅͨ·ºÍ°Ðµã£¬ÒÔ¼°ËùÉæ¼°µÄµ°°×¼ä»¥×÷ºÍÉú»¯µ÷¿Ø»úÖÆÉÐδÍêÈ«Ã÷È·¡£Òò´Ë£¬ÉîÈëÑо¿Mtb ptpAºÍMtb pknG¸ÉÈÅËÞÖ÷ÃâÒß·´Ó¦µÄ·Ö×Ó»úÀí£¬½«ÓÐÀûÓÚÌṩ»ùÓÚMtb-ËÞÖ÷ϸ°û»¥×÷½çÃæµÄ¿¹½áºËае㣬ΪÐÂÐͽáºË²¡Ô¤·À¼°ÖÎÁÆÒ©ÎïºÍÒßÃçµÄ¿ª·¢ÌṩвßÂÔ¡£Áõ´ä»ªÑо¿×éÒÔÍùÑо¿·¢ÏÖMtb ptpAÓëËÞÖ÷·ºËØ£¨Ub£©Ï໥×÷Ó㬲¢ÏȺó½ÒʾÁËMtb ptpAͨ¹ýÔÚϸ°ûÖÊ·ý»ñUb¼¤»î×ÔÉíÁ×Ëáø»îÐÔÒÔÒÖÖÆËÞÖ÷¹ÌÓÐÃâÒß·´Ó¦µÄ·Ö×Ó»úÖÆ£¨Nature Immunology, 2015£©£¬ÒÔ¼°Mtb ptpAÔÚϸ°ûºËÒÔ·ºËØ·ÇÒÀÀµµÄÐÎʽ´Ù½øÖ×Áöϸ°ûÔöÖ³µÄ·Ö×Ó»úÖÆ£¨Nature Communications, 2017£©¡£

½üÆÚ£¬Áõ´ä»ªÑо¿×éÓë±±¾©Ê¦·¶´óѧÇñС²¨½ÌÊÚÍŶÓÒÔ¼°vwinµÂÓ®Ñо¿Ëù¸ß¸£ÔºÊ¿ÍŶӵÄ×îкÏ×÷Ñо¿½ÒʾÁËMtb pknG¿ÉÓëËÞÖ÷·ºËØÏµÍ³µÄÁíÒ»Öֹؼüµ°°×¡ª·ºËØñîºÏø£¨E2£©UbcH7·¢ÉúÌØÒìÐÔ½áºÏ£¬²¢´ß»¯Ò»ÖַǾ­µäµÄÁ½²½·ºËØ»¯¼¶Áª·´Ó¦À´°ÐÏòµ÷¿ØËÞÖ÷·ºËØÏµÍ³£¬½ø¶øÒÖÖÆËÞÖ÷µÄ¹ÌÓÐÃâÒßÓ¦´ð¡£¾ßÌåÀ´Ëµ£¬Mtb pknGͬʱ¾ßÓзǾ­µäµÄ·ºËؼ¤»îø£¨E1£©ºÍ·ºËØÁ¬½Óø£¨E3£©»îÐÔ£¬²¢¿ÉÀûÓÃÆäË«¹¦ÄÜø»îÐÔ´Ù½øËÞÖ÷ϸ°ûÖеÄÖ×Áö»µËÀÒò×ÓÊÜÌåÏà¹ØÒò×Ó2£¨TRAF2£©ºÍTGF-¦Â¼¤»î¼¤Ã¸1£¨TAK1£©µÄ·ºËØ»¯¼°½µ½â£¬×îÖÕÒÖÖÆNF-¦ÊB¹ÌÓÐÃâÒßÐźÅͨ·µÄ»î»¯¡£

±¾Ñо¿µÄ¹Ø¼ü´´ÐµãºÍ¿ÆÑ§ÒâÒåΪ£º

1£©Ê״η¢ÏÖÁËMtb ÖÐͬʱ¾ßÓÐE1ºÍE3»îÐÔµÄЧӦµ°°×pknG¼°Æä°ÐÏòµÄËÞÖ÷µ°°×µ×ÎTRAF2ºÍTAK1£©¡£

2£©½ÒʾÁËMtbµ÷¿ØµÄ·ºËØ»¯¹ý³Ì¿ÉÒÔÓÉÁ½²½¼¶Áª·´Ó¦´ß»¯ÊµÏÖ¡£¾­µäµÄ·ºËØ»¯ÐÞÊÎÊÇÒ»¸öÓÉE1¡¢E2ºÍE3ÒÀ´Î´ß»¯µÄÈý²½Ã¸´Ù¼¶Áª·´Ó¦£¬¶øpknGÔò¿Éͨ¹ýÁ½²½½éµ¼µ×ÎïµÄ·ºËØ»¯ÐÞÊΡ£ÔÚÒ»²½·´Ó¦ÖУ¬pknGͨ¹ýÆäÐÂÐ͵ÄUbl½á¹¹ÓòÓëUbcH7»¥×÷£¬²¢×÷ΪE1´Ù½øUbÓë UbcH7µÄ¹²¼Û½áºÏ£¬Í¬Ê±¿É½øÒ»²½ÀûÓÃÆäÒìëÄø»îÐÔ´ß»¯Ub×ÔUbcH7-Ub¸´ºÏÎïÉϽâÀëÒÔ»ñµÃ»î»¯µÄUb¡£ÓÐȤµÄÊÇ£¬pknGÖ±½Ó´ß»¯UbÒÔÒìëļüµÄÐÎʽ½áºÏÖÁUbcH7µÄLys82λµã£¬Æä¼äÎÞÐèÐγÉÁòõ¥¼üÁ¬½ÓµÄpknG-UbÖмäÌ壬¶ø¾­µäµÄE1ͨ³£´ß»¯UbÒÔÁòõ¥¼üµÄÐÎʽ½áºÏÖÁUbcH7µÄCys86λµã£¬ÇÒÆä¼äÐèÒªÐγÉÁòõ¥¼üÁ¬½ÓµÄE1-UbÖмäÌå¡£ÔÚµÚ¶þ²½·´Ó¦ÖУ¬pknG¿É×÷ΪE3½«»î»¯µÄUb×ªÒÆÖÁµ×Îïµ°°×ÉÏ£¬²¢´Ù½øËüÃǵķºËØ»¯½µ½â¡£

3£©²ûÃ÷ÁËÔ­ºËÉúÎïµ÷¿ØËÞÖ÷·ºËØ»¯¹ý³ÌµÄÌØÊâÄÜÁ¿À´Ô´¡£¾­µäE1»î»¯UbµÄ¹ý³Ì¾­³£ÀûÓÃATpË®½âΪAMpÀ´ÌṩÄÜÁ¿£¬¶øpknG´Ù½øUb»î»¯µÄÄÜÁ¿À´Ô´ÓÚATpË®½âΪADpËùÊͷŵÄÄÜÁ¿¡£×ÛÉÏ£¬±¾Ñо¿µÄ´´ÐÂÐԳɹûË¢ÐÂÁ˶ÔÒÑÓзºËØ»¯´ß»¯»úÖÆµÄÈÏʶ£¬½ÒʾÁËÒ»ÖÖ²¡Ô­¾ú°ÐÏòËÞÖ÷·ºËØÏµÍ³µÄвßÂÔ£¬ÌṩÁË»ùÓÚ²¡Ô­-ËÞÖ÷½çÃæµÄ¿¹½áºËÖÎÁÆÐ°е㣨¼´Mtb pknGµÄ·Ç¾­µäE1ºÍE3ø»îÏà¹ØµÄUbl½á¹¹Óò£¬¸Ã½á¹¹ÓòÓë·ÇÖ²¡ÐÔ·ÖÖ¦¸Ë¾ú¼°ËÞÖ÷ϸ°û¼ä¼¸ºõÎÞͬԴÐÔ£©£¨Í¼1£©¡£

ͼ1. Mtb pknGͨ¹ý´ß»¯·Ç¾­µäµÄÁ½²½·ºËØ»¯¼¶Áª·´Ó¦ÒÖÖÆËÞÖ÷¹ÌÓÐÃâÒßµÄģʽͼ

Ïà¹ØÑо¿½á¹ûÒÑÔÚÏß·¢±íÓÚ¹ú¼ÊȨÍþÆÚ¿¯EMBO reportsÉÏ£¬ÌâΪ¡°M. tuberculosis protein kinase G impairs host immunity by acting as an unusual ubiquitinating enzyme¡±¡£Áõ´ä»ªÑо¿×éµÄÏîÄ¿Ñо¿Ô±Íô¾²¡¢²©Ê¿Ñо¿Éú¸ðÆÖÆÖºÍ˶ʿÑо¿ÉúÀ×Ôó»ÛΪ¸ÃÂÛÎĵĹ²Í¬µÚÒ»×÷Õߣ¬Öйú¿ÆÑ§ÔºvwinµÂÓ®Ñо¿ËùÁõ´ä»ªÑо¿Ô±¡¢±±¾©Ê¦·¶´óѧÇñС²¨½ÌÊÚÒÔ¼°Öйú¿ÆÑ§ÔºvwinµÂÓ®Ëù¸ß¸£ÔºÊ¿Îª±¾ÎĵĹ²Í¬Í¨Ñ¶×÷Õß¡£¸ÃÑо¿µÃµ½¹ú¼Ò×ÔÈ»¿ÆÑ§»ù½ðί¡¢Öйú¿ÆÑ§ÔºÕ½ÂÔÐÔÏȵ¼¿Æ¼¼×¨ÏBÀࣩ¡¢¹ú¼ÒÖØµãÑз¢¼Æ»®ÏîÄ¿¡¢¹ú¼Ò¿Æ¼¼ÖØ´óרÏîÒÔ¼°Öйú¿ÆÑ§ÔºÇàÄ괴дٽø»áÈ˲ÅÏîÄ¿µÄ×ÊÖú¡£

ÎÄÕÂÁ´½Ó£ºhttp://doi.org/10.15252/embr.202052175